Cargando…
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
BACKGROUND: Acute myeloid leukaemia (AML) is a deadly disease characterised by the uncontrolled proliferation of immature myeloid cells within the bone marrow. Altered regulation of DNA methylation is an important epigenetic driver of AML, where the hypoxic bone marrow microenvironment can help faci...
Autores principales: | Humphries, Sam, Bond, Danielle R., Germon, Zacary P., Keely, Simon, Enjeti, Anoop K., Dun, Matthew D., Lee, Heather J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500762/ https://www.ncbi.nlm.nih.gov/pubmed/37705055 http://dx.doi.org/10.1186/s13148-023-01566-x |
Ejemplares similares
-
The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019) -
Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019) -
Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses
por: Mannan, Abdul, et al.
Publicado: (2021) -
Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia
por: Dun, Matthew D., et al.
Publicado: (2020) -
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia
por: Murray, Heather C., et al.
Publicado: (2020)